2764例输血前、术前患者传染性指标检测结果分析

Analysis of infectious markers before transfusion and operation in 2764 blood recipients

目的探讨患者输血前和手术前血液传染性指标检测在院内感染控制中的临床意义。方法输血前、术前2764例患者,用化学发光法进行乙肝病毒表面抗原(HBsAg)、丙肝病毒抗体(抗-HCV)、梅毒特异性抗体(抗-TP)检测;用酶联免疫吸附试验(ELISA)进行艾滋病(抗-HIV)抗体检测;用甲苯胺红不加热血清反应素试验(TRUST)检测梅毒;用全自动生化分析仪检测丙氨酸转氨酶(ALT)。结果 HBsAg阳性159例(阳性率5.75%);抗-HCV阳性17例(0.62%);抗-HIV1/2待复检5例(0.18%),确诊阳性2例(0.07%);TRUST阳性31例(1.12%);梅毒特异性抗体阳性69例(2.49%);ALT阳性286例(10.34%)。结论进行输血前、术前传染性指标检测,对预防交叉感染、减少医患纠纷,有效控制院内感染有重要意义。

Objective To evaluate the importance of detection of serological infectious markers for pre - blood - transfusion and preoperative patients in hospital infection control. Methods For 2764 pre - blood - transfusion and preoperative patients, the serum markers （HBsAg, anti- HCV, anti- TP）were detected with chemiluminescence immune assay, the serum anti -HIV was detected with ELISA, the syphilis was detected with toluidine red unheated serum reagin test （TRUST）, the serum ALT was de- tected with automatic biochemistry analyzer. Results The positive rates were 5.75% for HBsAg, 0.62% for anti - HCV, 0.07% for anti - HIV, 1.12% for TRUST,2.49% for anti - TP and 10.34% for ALT. Conclusion There is important signifi- cance to detect serological infectious markers for pre - blood - transfusion and preoperative patients to prevent cross infection, reduce medical disputes and effectively control hospital infection.